Figure 2B shows the individual observed and predicted CD19+ vs. time profiles for four representative patients taking into account four different pathologies (i.e., neuromyelitis optica, Myasthenia gravis, multiple sclerosis and systemic lupus erythematosus). This evidence concerns the gene CD19 and systemic lupus erythematosus.